Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 10:34 am Purchase | 2024-11-08 | 13G | Teva Pharmaceutical Industries Limited TEVA | FMR LLC | 62,740,762 5.537% | 33,877,274 (+117.37%) | Filing History |
| 2024-04-09 10:26 am Purchase | 2024-04-01 | 13G | Teva Pharmaceutical Industries Limited TEVA | Phoenix Financial Ltd. | 54,144,997 4.830% | 54,144,997 (New Position) | Filing History |
| 2024-02-01 08:03 am Purchase | 2023-12-31 | 13G | Teva Pharmaceutical Industries Limited TEVA | Phoenix Financial Ltd. | 60,522,178 5.400% | 60,522,178 (New Position) | Filing History |
| 2023-06-09 12:32 pm Sale | 2023-06-12 | 13G | Teva Pharmaceutical Industries Limited TEVA | Capital Research Global Investors | 0 0.000% | -114,793,989 (Position Closed) | Filing History |
| 2023-02-13 3:32 pm Sale | 2023-02-14 | 13G | Teva Pharmaceutical Industries Limited TEVA | Capital Research Global Investors | 114,793,989 10.300% | -17,556,761 (-13.27%) | Filing History |
| 2022-02-11 12:22 pm Purchase | 2022-02-14 | 13G | Teva Pharmaceutical Industries Limited TEVA | Capital Research Global Investors | 132,350,750 12.000% | 2,210,503 (+1.70%) | Filing History |
| 2021-02-16 3:58 pm Purchase | 2021-02-16 | 13G | Teva Pharmaceutical Industries Limited TEVA | Capital Research Global Investors | 130,140,247 11.900% | 130,140,247 (New Position) | Filing History |
| 2021-02-11 4:18 pm Purchase | 2020-12-31 | 13G | American Well Corporation AMWL | TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA | 533,333 5.300% | 533,333 (New Position) | Filing History |
| 2021-02-03 1:13 pm Sale | 2020-12-31 | 13G | Teva Pharmaceutical Industries Limited TEVA | Wellington Management Group LLP | 310,793 0.030% | -80,813,203 (-99.62%) | Filing History |
| 2020-02-14 12:03 pm Purchase | 2019-12-31 | 13G | Teva Pharmaceutical Industries Limited TEVA | Capital Research Global Investors | 130,950,677 11.900% | 8,996,394 (+7.38%) | Filing History |